| Start Date | 2022-12-20 |
|---|---|
| Geographic Scope | National |
| Law | Public Law 117-244 |
| Type of Legislation | House Bill |
| Congress | 117 |
| Linked Proposal | Proposal:Cardiovascular Advances in Research and Opportunities Legacy Act |
| Source | View original on Congress.gov |
Description
Cardiovascular Advances in Research and Opportunities Legacy Act
This act addresses research, education, and awareness concerning valvular heart disease and its treatment. This disease is caused by damage to or disease affecting any valve that controls blood flow in the heart.
The National Institutes of Health may conduct or support research on the disease in consultation with the National Heart, Lung, and Blood Institute (NHLBI). The NHLBI must also conduct a workshop on mitral valve prolapse, which occurs when the valve between the chambers of the left side of the heart seals improperly.
The Department of Health and Human Services (HHS) must develop best practices to treat valvular heart disease. HHS may also carry out other projects to increase education and awareness of the disease.
Geographic Scope
National
Start Date
2022-12-20
Public Law Title
Cardiovascular Advances in Research and Opportunities Legacy Act